RFPi, Inc. is commercializing a transformational new medical imaging technology.
- Better knowledge at the time of surgery
- Better real-time decisions
- Improved clinical outcomes
This technology images and immediately analyzes Blood Flow Distribution (BFD, flow in vessels AND perfusion in tissues) in intact and diseased tissues at surgery.
- BFD data is not available to surgeons because BFD cannot be visualized in the visible light spectrum in current technology
- RFPi’s iCertainty™ technology is FDA-cleared as a 510(k) Class II device
- iCertainty™ can be used by all surgical sub-specialists in any procedure where data on BFD would impact on decision-making and/or clinical outcomes
RFPi-ARMUS Cloud Repository
- New knowledge engine platform
- Surgeon Web Portal for analysis and postsurgical review
- Repository allows for ongoing development of machine learning to provide predictive analytics
iCertainty™’s innovations deliver benefits to four key stakeholders for success in today’s marketplace:
- Patients – Clinical benefit, safer procedures with improved outcomes
- Physicians — Better decision-making at point-of-care, new knowledge, and predictive analytics for better patient care
- Provider facilities — Avoidance of unnecessary procedures, better clinical outcomes and quality of care, reduced readmission penalties, all impacting the bottom line
- Payers — Sustainable reduction in complications, lower cost care paths, better defined accountable surgical care practice